Our molecular docking analysis also showed that quercetin can combine with CDKN1A, MAPK1, RB1, TP53, NFKBIA, and MYC to activate the Hepatitis B and Hepatitis C pathways for anti-hepatitis. This evidence concerns the gene TP53 and hepatitis B virus infection.